A Guide To Lymphoma Clinical Trials
This actionable lymphoma guide lays out the considerations when managing your diagnosis to help you with the process and to make sure no step is missed along the way.
Lymphoma is a type of blood cancer that attacks lymphatic tissue and affects lymphocytes, also known as white blood cells. There are two types of lymphoma, Non-Hodgkin’s lymphoma, and Hodgkin’s lymphoma. Non-Hodgkin’s lymphoma represents 85% of all lymphoma cases in the United States.
Nearly 100,000 new cases of lymphoma were estimated in 2020 by the National Cancer Institute, and the 5-year relative survival rate is 72.6%. It represents 4.6% of all new cancer cases in the United States, as the 7th most common cancer type.
Trials Can Help
There are approximately 800 clinical trials for lymphoma that are currently recruiting patients in the United States right now.
Current clinical trials are researching new:
- Targeted therapies for new biomarkers
- Combinations of chemotherapies with other drugs
- Immunotherapy drugs, such as CAR T-cell therapy
- Idiotypic vaccination
Participating in a clinical trial not only progresses much needed research but gives patients access to these new innovative therapies years before the general population.
At Massive Bio, our mission is to enable cancer patients to have equal access to cutting-edge therapies and clinical trials, regardless of their location and/or financial stability.
Our Artificial Intelligence (AI) powered Clinical Trial Matching System connects patients and their treating oncologists to clinical trials according to their unique cancer case.
We enlist dedicated staff to collect medical records and treatment history and match patients to eligible trials near their home. We provide full support throughout your enrollment process to ensure logistics are handled so you can concentrate on your health.